2016 Q2 Form 10-Q Financial Statement

#000156459016022733 Filed on August 04, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2015 Q4 2015 Q2
Revenue $97.00K $17.00K $1.000K
YoY Change 9600.0% -63.83% -96.43%
Cost Of Revenue $526.0K $2.500M
YoY Change
Gross Profit -$429.0K -$2.500M
YoY Change
Gross Profit Margin -442.27% -14705.88%
Selling, General & Admin $50.77M $22.60M $21.10M
YoY Change 140.61% 117.31% 163.75%
% of Gross Profit
Research & Development $20.48M $20.50M $18.38M
YoY Change 11.42% 12.64% 33.19%
% of Gross Profit
Depreciation & Amortization $450.0K $130.0K $280.0K
YoY Change 60.71% 116.67% 460.0%
% of Gross Profit
Operating Expenses $71.25M $43.10M $39.50M
YoY Change 80.38% 50.7% 81.59%
Operating Profit -$71.92M -$45.60M -$39.50M
YoY Change 82.1% 81.82%
Interest Expense $601.0K $100.0K $119.0K
YoY Change 405.04% -50.0% -47.81%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$71.30M -$45.50M -$39.40M
YoY Change 80.96% 60.21% 83.26%
Income Tax $300.0K
% Of Pretax Income
Net Earnings -$71.32M -$45.78M -$39.38M
YoY Change 81.12% 61.4% 83.2%
Net Earnings / Revenue -73527.84% -269317.65% -3937800.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$629.3K -$452.6K -$392.8K
COMMON SHARES
Basic Shares Outstanding 113.2M 100.9M shares 100.3M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q2 2015 Q4 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $412.6M $215.1M $270.8M
YoY Change 52.38% -33.29% -23.61%
Cash & Equivalents $131.8M $102.1M $93.21M
Short-Term Investments $280.8M $113.0M $177.6M
Other Short-Term Assets $6.800M $2.200M $1.100M
YoY Change 518.18% 83.33% -64.52%
Inventory $2.867M
Prepaid Expenses
Receivables $300.0K
Other Receivables $1.300M
Total Short-Term Assets $423.9M $219.0M $273.4M
YoY Change 55.05% -32.54% -23.81%
LONG-TERM ASSETS
Property, Plant & Equipment $2.897M $2.203M $1.813M
YoY Change 59.79% 298.37% 262.6%
Goodwill
YoY Change
Intangibles $7.754M
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.111M $329.0K $333.0K
YoY Change 233.63% 14.63% 200.0%
Total Long-Term Assets $14.14M $2.907M $2.146M
YoY Change 558.76% 246.07% 251.23%
TOTAL ASSETS
Total Short-Term Assets $423.9M $219.0M $273.4M
Total Long-Term Assets $14.14M $2.907M $2.146M
Total Assets $438.0M $221.9M $275.5M
YoY Change 58.97% -31.82% -23.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.024M $1.672M $2.916M
YoY Change -64.88% -17.06% 164.13%
Accrued Expenses $27.49M $20.23M $16.46M
YoY Change 66.96% 46.4% 100.61%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $29.02M $21.90M $19.38M
YoY Change 49.77% 38.32% 107.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $200.0K $200.0K $300.0K
YoY Change -33.33% 100.0%
Total Long-Term Liabilities $197.0K $232.0K $340.0K
YoY Change -42.06% 71.85% 1788.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.02M $21.90M $19.38M
Total Long-Term Liabilities $197.0K $232.0K $340.0K
Total Liabilities $29.22M $22.13M $19.72M
YoY Change 48.18% 38.61% 110.73%
SHAREHOLDERS EQUITY
Retained Earnings -$783.7M -$662.6M -$577.9M
YoY Change 35.61% 33.01% 29.87%
Common Stock $11.00K $10.00K $10.00K
YoY Change 10.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $408.8M $199.8M $255.8M
YoY Change
Total Liabilities & Shareholders Equity $438.0M $221.9M $275.5M
YoY Change 58.97% -31.82% -23.35%

Cashflow Statement

Concept 2016 Q2 2015 Q4 2015 Q2
OPERATING ACTIVITIES
Net Income -$71.32M -$45.78M -$39.38M
YoY Change 81.12% 61.4% 83.2%
Depreciation, Depletion And Amortization $450.0K $130.0K $280.0K
YoY Change 60.71% 116.67% 460.0%
Cash From Operating Activities -$56.75M -$34.73M -$29.87M
YoY Change 89.99% 95.11% 76.02%
INVESTING ACTIVITIES
Capital Expenditures -$8.580M -$290.0K -$670.0K
YoY Change 1180.6% 222.22%
Acquisitions
YoY Change
Other Investing Activities $1.120M $57.02M $44.74M
YoY Change -97.5% 40.55% -166.27%
Cash From Investing Activities -$7.460M $56.72M $44.07M
YoY Change -116.93% 40.12% -165.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 20.76M 9.330M 2.600M
YoY Change 698.46% 232.03% 51.16%
NET CHANGE
Cash From Operating Activities -56.75M -34.73M -29.87M
Cash From Investing Activities -7.460M 56.72M 44.07M
Cash From Financing Activities 20.76M 9.330M 2.600M
Net Change In Cash -43.45M 31.32M 16.80M
YoY Change -358.63% 22.87% -120.3%
FREE CASH FLOW
Cash From Operating Activities -$56.75M -$34.73M -$29.87M
Capital Expenditures -$8.580M -$290.0K -$670.0K
Free Cash Flow -$48.17M -$34.44M -$29.20M
YoY Change 64.97% 94.47% 72.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q2 us-gaap Inventory Net
InventoryNet
2867000
CY2016Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6842000
CY2016Q2 us-gaap Assets Current
AssetsCurrent
423897000
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2897000
CY2016Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7754000
CY2016Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2375000
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1111000
CY2016Q2 us-gaap Assets
Assets
438034000
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1024000
CY2016Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
27485000
CY2016Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
513000
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
29022000
CY2016Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
197000
CY2016Q2 us-gaap Liabilities
Liabilities
29219000
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
11000
CY2016Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1192268000
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-783670000
CY2016Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
206000
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
408815000
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
438034000
CY2016Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2016Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
225000000
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
113685986
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
113685986
CY2016Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
97000
CY2015Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
1000
CY2016Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
526000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
526000
CY2016Q2 us-gaap License Costs
LicenseCosts
248000
us-gaap License Costs
LicenseCosts
248000
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20478000
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18379000
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
50768000
CY2016Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
601000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-71322000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
329000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
375000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2219000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
218989000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2203000
CY2015Q4 us-gaap Assets
Assets
221896000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1672000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20230000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
21902000
CY2015Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
232000
CY2015Q4 us-gaap Liabilities
Liabilities
22134000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
10000
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
862327000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-662586000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
11000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
199762000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
221896000
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
225000000
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
101938702
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101938702
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
97000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
4000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
5000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-71923000
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
113308000
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.63
CY2016Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-111000
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
2000000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
29636000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61854000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
254000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
355000
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">10. Recent Accounting Pronouncements</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued authoritative guidance related to accounting for credit losses on financial instruments that changes the impairment model for most financial assets and certain other instruments. For trade receivables and other instruments, entities will be required to use a new forward-looking expected loss model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. This guidance is effective for annual reporting periods beginning after December 15, 2019, including interim periods within those years, with early adoption permitted only as of annual reporting periods beginning after December 15, 2018. The Company is currently evaluating the impact of the adoption of this guidance on the Company&#8217;s consolidated financial statements.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March, April, and May 2016, the FASB issued updates to its authoritative guidance for revenue from contracts with customers. The updates clarify certain aspects of the revenue guidance, including but not limited to, the implementation guidance on principal versus agent considerations, the licensing implementation guidance, identification of performance obligations, assessment of the collectability criterion, presentation of sales taxes and other similar taxes, and measurement of noncash consideration. The authoritative guidance for revenue from contracts with customers to which these updates apply is effective for annual reporting periods beginning after December 15, 2017, with early adoption permitted only as of annual reporting periods beginning after December 15, 2016. Companies may use either a full retrospective or a modified retrospective approach to adopt this guidance. The Company is continuing to evaluate which transition approach to use and its impact, if any, on its consolidated financial statements.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2016, the FASB issued authoritative guidance related to accounting for employee share-based compensation which is intended to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, classification on the statement of cash flows, and accounting for forfeitures. This guidance is effective for annual reporting periods beginning after December 15, 2016, including interim periods within those years. The Company is currently evaluating the impact of the adoption of this guidance on the Company&#8217;s consolidated financial statements.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2016, the FASB issued authoritative guidance related to accounting for leases. This accounting guidance will require a lessee to recognize a lease liability and a right-of-use asset for all leases with lease terms of more than 12 months. This guidance is effective for annual reporting periods beginning after December 15, 2018, including interim periods within those years, and early adoption is permitted. The Company is currently evaluating the impact of the adoption of this guidance on the Company&#8217;s consolidated financial statements.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2014, the FASB issued authoritative accounting guidance related to an entity&#8217;s ability to continue as a going concern. This guidance explicitly requires management to assess an entity&#8217;s ability to continue as a going concern, and to provide related footnote disclosures in certain circumstances. The new standard is effective for annual reporting periods ending after December 15, 2016, and for annual periods and interim periods thereafter, with early adoption permitted. The Company early adopted this guidance in the first quarter of 2016 with no impact to its consolidated financial statements or related disclosures.</p></div>
CY2016Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
363093000
CY2016Q2 acad Regulatory Milestone Payment
RegulatoryMilestonePayment
8000000
CY2016Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8000000
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
246000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
738000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1500000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1500000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1500000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1500000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1100000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14404000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12196000
CY2016Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
134100000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y1M6D
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13883000
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7499000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
25838000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
22027000
CY2016Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
2144000
CY2016Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
723000
CY2016Q2 acad Accrued Clinical Development Services
AccruedClinicalDevelopmentServices
7636000
CY2015Q4 acad Accrued Clinical Development Services
AccruedClinicalDevelopmentServices
8805000
CY2016Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7054000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5722000
CY2016Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
11076000
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4508000
CY2016Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1719000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1195000
CY2016Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
280587000
CY2016Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
205000
CY2015Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
112996000
CY2015Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
12000
CY2015Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
14000
CY2015Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
213059000
CY2016Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
281600000
CY2016Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10344827
CY2016Q2 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
14300000
CY2016Q2 acad Prior Stockholders Percentage Of Equity Holding
PriorStockholdersPercentageOfEquityHolding
0.10

Files In Submission

Name View Source Status
0001564590-16-022733-index-headers.html Edgar Link pending
0001564590-16-022733-index.html Edgar Link pending
0001564590-16-022733.txt Edgar Link pending
0001564590-16-022733-xbrl.zip Edgar Link pending
acad-10q_20160630.htm Edgar Link pending
acad-20160630.xml Edgar Link completed
acad-20160630.xsd Edgar Link pending
acad-20160630_cal.xml Edgar Link unprocessable
acad-20160630_def.xml Edgar Link unprocessable
acad-20160630_lab.xml Edgar Link unprocessable
acad-20160630_pre.xml Edgar Link unprocessable
acad-ex10_319.htm Edgar Link pending
acad-ex31_6.htm Edgar Link pending
acad-ex32_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending